Zenith® p-Branch® Endovascular Graft Pivotal Study
A legfontosabb adatok
- Hol
- Atlanta, Baltimore, Birmingham, Boca Raton, Dallas, Durham, Hartford, Houston, Indianapolis, Irving, Los Angeles, Milwaukee, Minneapolis, New York, Philadelphia, Phoenix, Pittsburgh, Portland, Rochester, San Francisco, St Louis, Stanford, Tampa és Worcester (Egyesült Államok)Mind a 27 helyszín megnézése
Helyszínek itt: Egyesült Államok
- Emory University HospitalAtlanta, Egyesült ÁllamokNo longer taking part
- Johns Hopkins HospitalBaltimore, Egyesült ÁllamokNo longer taking part
- University of Alabama Birmingham HosptialBirmingham, Egyesült ÁllamokNo longer taking part
- Boca Raton Community HospitaBoca Raton, Egyesült ÁllamokNo longer taking part
- UT SouthwesternDallas, Egyesült ÁllamokNo longer taking part
- Duke University Medical CenterDurham, Egyesült ÁllamokNo longer taking part
- Hartford HospitalHartford, Egyesült ÁllamokNo longer taking part
- Michael E. DeBakey VA Medical CenterHouston, Egyesült ÁllamokNo longer taking part
- The Methodist Hospital - Smith TowerHouston, Egyesült ÁllamokNo longer taking part
- Methodist Hospital of IndianaIndianapolis, Egyesült ÁllamokNo longer taking part
- Baylor Scott and White Research InstituteIrving, Egyesült ÁllamokNo longer taking part
- Ronald Reagan UCLA Medical CenterLos Angeles, Egyesült ÁllamokNo longer taking part
- Aurora Saint Luke's Medical CenterMilwaukee, Egyesült ÁllamokNo longer taking part
- Minneapolis Heart Inst. FoundationMinneapolis, Egyesült ÁllamokNo longer taking part
- Mount Sinai RooseveltNew York, Egyesült ÁllamokNo longer taking part
- New York University Langone Medical CenterNew York, Egyesült ÁllamokNo longer taking part
- Hospital of the University of PennsylvaniaPhiladelphia, Egyesült ÁllamokNo longer taking part
- St. Joseph's Hospital and Medical Center-Dignity HealthPhoenix, Egyesült ÁllamokNo longer taking part
- University of Pittsburgh Medical CenterPittsburgh, Egyesült ÁllamokNo longer taking part
- Oregon Health and Science UniversityPortland, Egyesült ÁllamokNo longer taking part
- Mayo Clinic - RochesterRochester, Egyesült ÁllamokNo longer taking part
- Kaiser PermanenteSan Francisco, Egyesült ÁllamokNo longer taking part
- Barnes Jewish Hospital PlazaSt Louis, Egyesült ÁllamokNo longer taking part
- Mercy Hospital St. LouisSt Louis, Egyesült ÁllamokNo longer taking part
- Stanford University Medical SchoolStanford, Egyesült ÁllamokNo longer taking part
- Tampa General HospitalTampa, Egyesült ÁllamokNo longer taking part
- University of Massachusetts Medical SchoolWorcester, Egyesült ÁllamokNo longer taking part
A vizsgálat adatai
- Ki végzi
- Cook Research Incorporated
- Azonosító
- NCT02396199
- A regiszteradat frissítve
- 2025. február 19.
- Eredeti leírás
The Zenith® p-Branch® Pivotal Study is a clinical trial approved by FDA to study the safety and effectiveness of the Zenith® p-Branch® endovascular graft in combination with the Atrium iCAST™ covered stents in the treatment of abdominal aortic aneurysms.A teljes eredeti leírásKevesebb
Zenith® p-Branch® Pivotal Study
The Zenith® p-Branch® Pivotal Study is a clinical trial approved by FDA to study the safety and effectiveness of the Zenith® p-Branch® endovascular graft in combination with the Atrium iCAST™ covered stents in the treatment of abdominal aortic aneurysms.
Bevonási feltételek: Pararenal or juxtarenal AAA ≥5.0 cm in diameter or 2 times the normal aortic diameter; Pararenal or juxtarenal AAA with history of growth ≥0.5 cm/year; Saccular aneurysm with aortic diameter greater than 1.5 times the normal aortic diameter that is deemed to be at risk for rupture based upon physician interpretation.
Kizáró feltételek: Simultaneously participating in another investigative device or drug study. (The patient must have completed the primary endpoint of any previous study at least 30 days prior to enrollment in this study.); Age <18 years; Life expectancy <2 years; Pregnant, breast-feeding, or planning on becoming pregnant within 60 months; Inability or refusal to give informed consent by the patient or a legally authorized representative; Unwilling or unable to comply with the follow-up schedule; Additional medical restrictions as specified in the Clinical Investigation Plan; Additional anatomical restrictions as specified in the Clinical Investigation Plan.